Canaccord Genuity Group upgraded shares of Healwell AI (TSE:AID – Free Report) to a moderate buy rating in a report released on Tuesday,Zacks.com reports.
Separately, TD Securities upgraded shares of Healwell AI to a “strong-buy” rating in a report on Thursday, April 2nd. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Buy rating to the stock. According to data from MarketBeat, Healwell AI has an average rating of “Strong Buy”.
Healwell AI Price Performance
Further Reading
- Five stocks we like better than Healwell AI
- Quantum Earnings Could Decide Whether the Sector’s Sell-Off Has Gone Too Far
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
Receive News & Ratings for Healwell AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healwell AI and related companies with MarketBeat.com's FREE daily email newsletter.
